ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0134

Long-Term Clinical Outcomes Following Pediatric AKI

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Su, Licong, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
  • Qihong, Liang, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
  • Nie, Sheng, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
  • Xu, Xin, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
Background

Previous studies on the long-term outcomes following pediatric AKI have yielded conflicting evidence.

Methods

This retrospective cohort study data was drawn from the China Renal Data System (CRDS) between 2013 and 2023. Children (30 days-18 years) with surviving AKI were enrolled in this study. AKI was defined according to the KDIGO guidelines, and propensity score matching (PSM) was implemented (1:3 ratio) to establish non-AKI comparators. The primary outcome was major adverse kidney events (MAKE, (a composite of death, long-term kidney failure [KRT], or new-onset chronic kidney disease [CKD]), and secondary outcomes comprised individual component endpoints and cardiovascular mortality. Multivariate Cox hazard regression models and competing risks regression were performed to explore the relationship between AKI and outcomes, as well as to conduct subgroup analyses according to patient characteristics.

Results

Among the 44,693 children (mean [SD] age, 6.1 [5.5] years; 27,521 boys [61.6%]) included in this study, 10,664 were survived AKI. The multivariate Cox model showed that AKI survivors demonstrated significantly higher risks of MAKE (adjusted hazard ratio [aHR]: 1.43 , 95% confidence interval [CI] 1.32-1.55), all-cause mortality (aHR: 1.42, 95%CI, 1.30-1.55), cardiovascular mortality (aHR: 1.42, 95%CI, 1.30-1.55), KRT (aHR: 3.00 , 95%CI, 2.24, 4.02), and CKD (aHR: 1.32, 95%CI, 1.21,1.44) compared to controls. The associations were consistent in various subgroups (Figure).

Conclusion

Children surviving AKI were at higher long-term risk of MAKE, all-cause and CVD mortality, KRT and CKD versus hospitalized comparators.

Digital Object Identifier (DOI)